Trials / Unknown
UnknownNCT03654612
Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies
A Single Arm,Open Clinical Study of Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- China International Medical Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This open, single-arm, exploratory study looked at the efficacy and safety of apatinib in combination with S-1 as second-line treatment of advanced head and neck malignancies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apatinib | Apatinib 500mg qd plus S-1 50mg bid d1-d14/28d cycle |
Timeline
- Start date
- 2018-10-16
- Primary completion
- 2020-03-01
- Completion
- 2021-09-01
- First posted
- 2018-08-31
- Last updated
- 2018-10-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03654612. Inclusion in this directory is not an endorsement.